help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 57, No. 2 250-253
doi:10.1210/jcem-57-2-250
Copyright © 1983 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROSS, D. S.
Right arrow Articles by RIDGWAY, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROSS, D. S.
Right arrow Articles by RIDGWAY, E. C.

Use of Adjunctive Potassium Iodide after Radioactive Iodine (131I) Treatment of Graves' Hyperthyroidism*

DOUGLAS S. ROSS, GILBERT H. DANIELS, PAUL DE STEFANO{dagger}, FARAHE MALOOF and E. CHESTER RIDGWAY

Thyroid Unit, Department of Medicine, Massachusetts General Hospital, and Harvard Medical School Boston, Massachusetts 02114

Address requests for reprints to: Dr. Douglas S. Ross, Thyroid Unit, Massachusetts General Hospital, Boston, Massachusetts 02114.

One hundred and nineteen patients with Graves' hyperthyroidism who were treated with 131I alone or 131I followed by potassium iodide (131I+KI) were studied retrospectively. Patients in both groups who required only a single dose of 131I for successful treatment of hyperthyroidism had similar age, gland size, 24-h radioactive iodine uptake, pretreatment serum T4 concentrations, and radioactive iodine treatment dose. Seven weeks after 131I, mean serum T4 concentrations were 12.3 ± 6.1 µg/dl (mean ± SD) in patients who received 131I alone and 8.0 ± 3.9 µg/dl in patients who received 131I+KI (P < 0.001). Sixty percent of the patients who received 131I+KI and remained euthyroid 1 yr after 131I treatment developed documented transient hypothyroidism while receiving KI (serum T4, 1.4 ± 0.9 µg/dl). Patients with transient hypothyroidism receiving KI had larger estimated thyroid gland weights when hypothyroid than patients whose hypothyroidism was permanent (32 ± 6 vs. 16 ± 11 g; P < 0.001). The overall incidence of hypothyroidism 1 yr after treatment with 131I was 58% in each of the two groups. Sixteen percent of each group were not successfully treated by a single dose of 131I and required further therapy. Adjunctive KI effectively treated thyrotoxicosis more rapidly than 131I alone without adversely affecting outcome at 1 yr; however, patients taking KI more often develop transient hypothyroidism.

* This work was supported in part by NIH Research Grants AM-16791 and AM-07028.

{dagger} Current address: Matthew Thorton Health Plan, 591 West Hollis Street, Nashua, New Hampshire 03062.

Received December 3, 1982.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Rivkees, C. Sklar, and M. Freemark
The Management of Graves' Disease in Children, with Special Emphasis on Radioiodine Treatment
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3767 - 3776.
[Full Text]


Home page
Arch Intern MedHome page
P. S. Denker
Hyperthyroidism With a Low Radioactive Iodine Uptake
Arch Intern Med, November 1, 1991; 151(11): 2326 - 2330.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
D. S. ROSS, E. C. RIDGWAY, and G. H. DANIELS
Successful Treatment of Solitary Toxic Thyroid Nodules with Relatively Low-Dose Iodine-131, with Low Prevalence of Hypothyroidism
Ann Intern Med, October 1, 1984; 101(4): 488 - 490.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society